Tigecycline

This product is for research use only, not for human use. We do not sell to patients.

Tigecycline
For small sizes, please check our retail website as below: www.invivochem.com
Size Price Stock
250mg$300In Stock
500mg$500In Stock
1g$750In Stock

Cat #: V5447 CAS #: 220620-09-7 Purity ≥ 98%

Description: Tigecycline (GAR936; GAR-936; TYGACL) is a potent tetracycline antibiotic which is bacteriostatic.

References: Jitkova Y, et al. A novel formulation of tigecycline has enhanced stability and sustained antibacterial and antileukemic activity. PLoS One. 2014 May 28;9(5):e95281.

Top Publications Citing Invivochem Products
Publications Citing InvivoChem Products

Product Promise

Promise
Molecular Weight (MW)585.65
Molecular FormulaC29H39N5O8
CAS No.220620-09-7
SynonymsGAR-936; GAR936; GAR936; TYGACL; Tigecycline
ProtocolIn VitroTigecycline (0.63-30 μM, pre-incubated for 4 days, treated for 72 h) inhibits AML2 cells and HL-60 cells, IC50 4.72±0.54 and 3.06±0.85 μM (freshly prepared), respectively. Tigecycline inhibits AML2 cells and HL-60 cells, IC50 5.64±0.55 and 4.27±0.45 μM, respectively (pre-incubation for 1 day). Tigecycline inhibits AML2 cells and HL-60 cells, IC50 5.02±0.60 and 4.39±0.44 μM, respectively (pre-incubation for 2 day). Tigecycline inhibits AML2 cells and HL-60 cells, IC50 4.09±0.41, and 3.95±0.39 μM, respectively (pre-incubation for 3 days). After 4 days of pre-incubation in saline, Tigecycline lost its ability to kill TEX human leukemia cells (from freshly prepared ICs50~5 μM 到 IC50>After 50 days of pre-incubation with 4 μM), measured by the CellTiter Flour assay
In VivoPeak plasma concentration (C.max), terminal half-life (t1/2), the clearance rate (CL) and volume of distribution (Vz) of Tigecycline in normal saline were 22.8 μg/mL, 108.9 min, 1912.2 min*μg/mL, 26.1 mL/min/kg, and 4109.4 mL/kg, respectively. Peak plasma concentration (C.max), terminal half-life (t1/2), area under the concentration-time curve (AUC), clearance (CL), and volume of distribution (Vz) of 15.7 μg/mL, 110.3 min, 2036.5 min*μg/mL, 24.6 mL/min/kg, 3906.2 mL/kg Tigecycline in the formulation (60 mg/mL pyruvate, 3 mg/mL ascorbic acid, pH 7 in normal saline)
Animal modelNOD/SCID mice with OCI-AML2 acute myeloid leukemia (AML) xenograft model
Dosages50 mg/kg
AdministrationIntraperitoneal injection; twice a day; for 11 days
These protocols are for reference only. InvivoChem does not independently validate these methods.
Preparing Stock Solutions
Solvent volume to be added Mass (the weight of a compound)
Mother liquor concentration 1mg5mg10mg20mg
1mM1.7075 mL8.5375 mL17.0750 mL34.1501 mL
5mM0.3415 mL1.7075 mL3.4150 mL6.8300 mL
10mM0.1708 mL0.8538 mL1.7075 mL3.4150 mL
20mM0.0854 mL0.4269 mL0.8538 mL1.7075 mL
Quality Control Documentation
The molarity calculator equation
Mass(g) = Concentration(mol/L) × Volume(L) × Molecular Weight(g/mol)
Mass
=
Concentration
×
Volume
×
Molecular Weight*
The dilution calculator equation
Concentration(start) × Volume(start) = Concentration(final) × Volume(final)

This equation is commonly abbreviated as: C1 V1 = C2 V2

Concentration(start)
C1
×
Volume(start)
V1
=
Concentration(final)
C2
×
Volume(final)
V2
Step One: Enter information below
Dosage mg/kg Average weight of animals g Dosing volume per animal µL Number of animals
Step Two: Enter the in vivo formulation
%DMSO + % + %Tween 80 + %ddH2O

Calculation Results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in µL DMSO(Master liquid concentration mg/mL) ,Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation: Take µL DMSO master liquid, next add µL PEG300, mix and clarify, next add µL Tween 80,mix and clarify, next add µL ddH2O,mix and clarify.
Note:
  • (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
  • (2) Be sure to add the solvent(s) in order.